SCHEMBL8613055

SCHEMBL8613055

CCN(CC)CCCCCCCO

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
LMNA P02545 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TSHR P16473 1/20 0.48
PAOX Q6QHF9 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 2/20 0.39
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
BCHE P06276 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37
TERT O14746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8612471 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL1404088 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL1404042 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL1404022 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL3922842 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL8616701 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL1404074 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL1404113 1.00 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10MEN1KMT2A
SCHEMBL9075 0.97 SMN1; SMN2 (0.45) ALDH1A1LMNAHSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL11579673 0.94 SMN1; SMN2 (0.43) ALDH1A1LMNAHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0720597-B1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMA INC (US) 1998-04-29 EP disclosed
US-5693674-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-12-02 US disclosed
US-5691384-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-11-25 US disclosed
US-5684004-A ANTINEOPLASTIC AGENTS, ANTIATHEROSCLEROTIC AGENTS, HYPOCHOLESTEROLEMIC AGENTS MERRELL PHARMACEUTICALS, INC. (US) 1997-11-04 US disclosed
EP-0794771-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1997-09-17 EP disclosed
EP-0720597-A1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMACEUTICALS INC. (US) 1996-07-10 EP disclosed
US-5525633-A ANTITUMOR AGENTS, ANTICHOLESTEROL AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1996-06-11 US disclosed
WO-1996016646-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1996-06-06 WO disclosed
WO-1995008528-A1 TRIARYL-ETHYLENE DERIVATIVES FOR USE IN THERAPY MERRELL PHARMACEUTICALS INC. (US) 1995-03-30 WO disclosed